Financhill
Buy
60

ADMA Quote, Financials, Valuation and Earnings

Last price:
$17.44
Seasonality move :
2.93%
Day range:
$17.08 - $17.96
52-week range:
$4.16 - $23.64
Dividend yield:
0%
P/E ratio:
62.14x
P/S ratio:
10.79x
P/B ratio:
17.74x
Volume:
6.9M
Avg. volume:
3.1M
1-year change:
325.43%
Market cap:
$4.1B
Revenue:
$258.2M
EPS (TTM):
$0.28

Earnings Data

Next earnings date for ADMA
Feb 28
2025
Most recent earnings per share
$0.15
Beat by $0.02
(Nov 7/2024)
Consensus Estimate
$0.13
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADMA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $113.4M -- -- $0.16 --
11/07/2024 Q3 $105.9M $119.8M $0.15 $0.13 $0.02
08/08/2024 Q2 $86.4M $107.2M $0.13 $0.08 $0.05
05/09/2024 Q1 $77.3M $81.9M $0.08 $0.05 $0.03
02/28/2024 Q4 $73M $73.9M -$0.08 $0.02 -$0.10
11/08/2023 Q3 -- -- $0.01 -$0.01 $0.02
08/09/2023 Q2 -- -- -$0.03 -$0.03 -$0.00
05/10/2023 Q1 -- -- -$0.03 -$0.04 $0.01
03/23/2023 Q4 -- -- -$0.06 -$0.07 $0.01
11/09/2022 Q3 -- -- -$0.08 -$0.07 -$0.01
08/10/2022 Q2 -- -- -$0.07 -$0.08 $0.01
05/11/2022 Q1 -- -- -$0.13 -$0.08 -$0.05
03/24/2022 Q4 -- -- -$0.09 -$0.09 $0.00
11/10/2021 Q3 -- -- -$0.13 -$0.14 $0.01
08/11/2021 Q2 -- -- -$0.15 -$0.16 $0.01
05/12/2021 Q1 -- -- -$0.16 -$0.17 $0.01
03/25/2021 Q4 -- -- -$0.20 -- --
11/05/2020 Q3 -- -- -$0.19 -- --
08/05/2020 Q2 -- -- -$0.23 -- --
05/06/2020 Q1 -- -- -$0.26 -- --
03/12/2020 Q4 -- -- -$0.18 -- --
11/06/2019 Q3 -- -- -$0.19 -- --
08/08/2019 Q2 -- -- -$0.25 -- --
05/08/2019 Q1 -- -- -$0.28 -- --
03/13/2019 Q4 -- -- -$0.39 -- --
11/08/2018 Q3 -- -- -$0.33 -- --
08/10/2018 Q2 -- -- -$0.35 -- --
05/14/2018 Q1 -- -- -$0.39 -- --
03/05/2018 Q4 -- -- -$0.29 -- --
11/03/2017 Q3 -- -- -$0.59 -- --
08/11/2017 Q2 -- -- -$0.55 -- --
03/31/2017 Q1 -- -- -$0.51 -- --
02/24/2017 Q4 -- -- -$0.35 -- --
09/30/2016 Q3 -- -- -$0.34 -- --
06/30/2016 Q2 -- -- -$0.50 -- --
03/31/2016 Q1 -- -- -$0.43 -- --
12/31/2015 Q4 -- -- -$0.45 -- --
09/30/2015 Q3 -- -- -$0.48 -- --
06/30/2015 Q2 -- -- -$0.44 -- --
03/31/2015 Q1 -- -- -$0.37 -- --
12/31/2014 Q4 -- -- -$0.38 -- --

ADMA Biologics Earnings Questions

  • How Much did ADMA Biologics Generate in Revenue Last Quarter?

    ADMA Biologics reported $119.8M worth of top line sales in its most recent quarter.

  • Did ADMA Biologics Beat Earnings Last Quarter?

    ADMA Biologics announced earnings per share of $0.15 which represents a beat of analyst forecast a $0.13 per share.

  • Is ADMA Biologics Profitable?

    ADMA Biologics reported $59.7M that represents $0.24 per share over the last quarter.

  • What is the Analyst Consensus for ADMA Biologics EPS Next Year?

    ADMA Biologics's earnings are forecast to decrease from -$0.13 per share to -$0.03 per share next year representing a decrease of -90.91%.

  • When is ADMA Biologics's Earnings Date?

    ADMA Biologics's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.11% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 16.63% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 1.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock